Search

Your search keyword '"Heart -- Growth"' showing total 167 results
Start Over Descriptor "Heart -- Growth"
167 results on '"Heart -- Growth"'

1. University of Alabama at Birmingham Researcher Describes Findings in Cardiomegaly (FGFR4 Is Required for Concentric Growth of Cardiac Myocytes during Physiologic Cardiac Hypertrophy)

Subjects
Chronic kidney failure -- Research, Heart enlargement -- Research, Heart -- Growth, Fibroblast growth factors -- Reports -- Growth -- Research, Company growth, Health, The University of Alabama at Birmingham -- Reports -- Growth
Abstract

2024 NOV 1 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- New research on cardiomegaly is the subject of a new report. According to [...]

Published
2024

2. Recent Findings from Technical University Dresden (TU Dresden) Has Provided New Information about Obesity, Fitness and Wellness (A Multiphysical Computational Model of Myocardial Growth Adopted To Human Pathological Ventricular Remodelling)

Subjects
Heart -- Growth, Physical fitness -- Research -- Models -- Analysis -- Health aspects -- Reports, Computer simulation -- Research -- Models -- Analysis -- Health aspects -- Reports, Computer-generated environments -- Research -- Models -- Analysis -- Health aspects -- Reports, Company growth, Health
Abstract

2023 JUL 22 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Obesity, Fitness and Wellness. According to news [...]

Published
2023

3. Wearable Cardioverter Defibrillator Market is set to Reach US$ 1,538.50 million at a CAGR of 10.5% from the forecast period 2023 to 2031 | Growth Plus Reports

Subjects
Heart -- Growth, Defibrillators -- Forecasts and trends -- Reports, Company growth, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Pune: Growth Plus Reports has issued the following news release: According to the latest report published by Growth Plus Reports, the global Wearable Cardioverter Defibrillator Market is expected to clock [...]

Published
2023

4. Wearable Cardioverter Defibrillator Market is set to Reach US$ 1,538.50 million at a CAGR of 10.5% from the forecast period 2023 to 2031 | Growth Plus Reports

Subjects
Heart -- Growth, Defibrillators -- Forecasts and trends -- Reports, Company growth, Market trend/market analysis, Banking, finance and accounting industries
Abstract

(GlobeNewswire) - According to the latest report published by Growth Plus Reports, the global Wearable Cardioverter Defibrillator Market is expected to clock US$ 1,538.50 million by 2031 and to grow [...]

Published
2023

5. p38 Mitogen-activated protein kinase regulates chamber-specific perinatal growth in heart

Author

Yokota, Tomohiro, Li, Jin, Huang, Jijun, Xiong, Zhaojun, Zhang, Qing, Chan, Tracey, Ding, Yichen, Rau, Christoph, Sung, Kevin, Ren, Shuxun, Kulkarni, Rajan, Hsiai, Tzung, Xiao, Xinshu, Touma, Marlin, Minamisawa, Susumu, and Wang, Yibin

Subjects
Pulmonary hypertension -- Comparative analysis, Apoptosis -- Growth -- Comparative analysis, Newborn infants -- Comparative analysis, Mitogens -- Comparative analysis, Protein kinases -- Growth -- Comparative analysis, Phosphatases -- Comparative analysis -- Growth, Heart -- Growth, Company growth, Health care industry
Abstract

In the mammalian heart, the left ventricle (LV) rapidly becomes more dominant in size and function over the right ventricle (RV) after birth. The molecular regulators responsible for this chamber-specific differential growth are largely unknown. We found that cardiomyocytes in the neonatal mouse RV had lower proliferation, more apoptosis, and a smaller average size compared with the LV. This chamber-specific growth pattern was associated with a selective activation of p38 mitogenactivated protein kinase (MAPK) activity in the RV and simultaneous inactivation in the LV. Cardiomyocyte-specific deletion of both the Mapk14 and Mapk11 genes in mice resulted in loss of p38 MAPK expression and activity in the neonatal heart. Inactivation of p38 activity led to a marked increase in cardiomyocyte proliferation and hypertrophy but diminished cardiomyocyte apoptosis, specifically in the RV. Consequently, the p38-inactivated hearts showed RV-specific enlargement postnatally, progressing to pulmonary hypertension and right heart failure at the adult stage. Chamber-specific p38 activity was associated with differential expression of dual-specific phosphatases (DUSPs) in neonatal hearts, including DUSP26. Unbiased transcriptome analysis revealed that IRE1[alpha]/XBP1-mediated gene regulation contributed to p38 MAPK-dependent regulation of neonatal cardiomyocyte proliferation and binucleation. These findings establish an obligatory role of DUSP/p38/ IRE1[alpha] signaling in cardiomyocytes for chamber-specific growth in the postnatal heart., Introduction In the fetal mammalian heart, when both chambers contribute to a common circulation, the right ventricle (RV) is equivalent in size to the left ventricle (LV) and even dominant [...]

Published
2020
Full Text
View/download PDF

6. Global Cardiac Ablation Device Market Set for Remarkable Growth, Fueled by Rising Demand for Minimally Invasive Procedures and Technological Advancements

Subjects
Arrhythmia -- Reports, Heart -- Growth, Company growth, Banking, finance and accounting industries
Abstract

(GlobeNewswire) - The 'Global Cardiac Ablation Devices Market' report has been added to ResearchAndMarkets.com's offering. Rising incidents of cardiac arrhythmia and the increasing demand for minimally invasive procedures boost the [...]

Published
2023

7. Global Cardiac Ablation Device Market Set for Remarkable Growth, Fueled by Rising Demand for Minimally Invasive Procedures and Technological Advancements

Subjects
Arrhythmia -- Forecasts and trends, Heart -- Growth, Company growth, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following news release: The 'Global Cardiac Ablation Devices Market' report has been added to ResearchAndMarkets.com's offering. Rising incidents of cardiac arrhythmia and the [...]

Published
2023

9. Asia Pacific Artificial Heart Market Research Report 2023-2028: Government Initiatives, Unhealthy Lifestyles and Cardiovascular Risks Propel Market Growth

Subjects
Coronary heart disease -- Reports -- Forecasts and trends, Prosthesis -- Reports -- Forecasts and trends, Implants, Artificial -- Reports -- Forecasts and trends, Marketing research -- Forecasts and trends -- Reports, Heart -- Growth, Company growth, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Asia Pacific Artificial Heart Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F. Segmented By Type (Ventricular Assist [...]

Published
2023

10. p38 MAPK reins in right ventricular growth

Author

Wu, Tongbin and Chen, Ju

Subjects
Protein kinases -- Growth, Heart -- Growth, Developmental biology -- Growth, Company growth, Health care industry
Abstract

The right ventricle (RV) is involved in systemic circulation in the fetal mammalian heart but quickly transitions to being solely responsible for pulmonary circulation after birth when the left ventricle (LV) becomes the systemic ventricle. To handle the increased workload, LV growth greatly outpaces that of the RV during postnatal stages. However, the molecular basis for this differential growth pattern between the 2 chambers is largely unknown. In this issue of the JCI, Yokota et al. reveal that the p38 mitogen-activated protein kinase (MAPK)/IRE1[alpha]/XBP1 axis specifically controls postnatal RV growth by suppressing cell cycle regulatory genes., Right versus left ventricle and related cardiomyopathies During the early stages of mammalian heart development, first-heart-field progenitors give rise to the left ventricle (LV), while second-heart-field progenitors contribute to the [...]

Published
2020
Full Text
View/download PDF

11. Acutus Medical to Present at the 43rd Annual Canaccord Growth Conference

Subjects
Heart -- Growth, Company growth, Banking, finance and accounting industries, Business
Abstract

CARLSBAD, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ('Acutus') (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced [...]

Published
2023

12. Congestive Heart Failure Market to Observe Impressive Growth During the Forecast Period (2022-2032) - DelveInsight | Key Companies - Novartis, Bayer, Eli Lilly, Otsuka, Cytokinetics, Mesoblast

Subjects
Lexicon Pharmaceuticals Inc. -- Forecasts and trends, Bayer AG -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Novartis AG -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Novo Nordisk A/S -- Forecasts and trends, Eli Lilly and Co. -- Forecasts and trends, Congestive heart failure -- Forecasts and trends, Brand equity -- Forecasts and trends, Heart -- Growth, Company growth, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-June 7, 2023-: Congestive Heart Failure Market to Observe Impressive Growth During the Forecast Period (2022-2032) - DelveInsight | Key Companies - Novartis, Bayer, Eli Lilly, Otsuka, Cytokinetics, Mesoblast [...]

Published
2023

13. The Global Holter Monitor Market is Projected to Boost at a Moderate Growth Rate of ~6% by 2027 | DelveInsight

Subjects
Abbott Laboratories (Abbott Park, Illinois) -- Forecasts and trends, Boston Scientific Corp. -- Forecasts and trends, Medical test kit industry -- Forecasts and trends, Heart beat -- Growth, Atrial fibrillation -- Forecasts and trends, Medical equipment and supplies industry -- Forecasts and trends, Heart -- Growth, Pharmaceutical industry -- Forecasts and trends, Company growth, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

New York, USA, April 13, 2023 (GLOBE NEWSWIRE) -- The Global Holter Monitor Market is Projected to Boost at a Moderate Growth Rate of ~6% by 2027 | DelveInsight The [...]

Published
2023

14. Implantable Cardiac Monitor Market Size to Surpass US$ 773.78 Billion by 2030 - Growth Plus Reports

Subjects
Prosthesis -- Statistics, Implants, Artificial -- Statistics, Arrhythmia -- Statistics, Patient monitoring equipment -- Statistics, Heart -- Growth, Company growth, General interest, News, opinion and commentary
Abstract

Newark: According to the deep-dive market assessment study by Growth Plus Reports, the global implantable cardiac monitor market was valued at US$ 509.60 billion in 2021 and is expected to [...]

Published
2023

15. Implantable Cardiac Monitor Market Size to Surpass US$ 773.78 billion by 2030 - Growth Plus Reports

Subjects
Prosthesis -- Statistics, Implants, Artificial -- Statistics, Atrial fibrillation -- Forecasts and trends -- Statistics -- Reports, Patient monitoring equipment -- Statistics, Heart -- Growth, Company growth, Market trend/market analysis, Banking, finance and accounting industries
Abstract

(GlobeNewswire) - According to the deep-dive market assessment study by Growth Plus Reports, the global implantable cardiac monitor market was valued at US$ 509.60 billion in 2021 and is expected [...]

Published
2023

16. Implantable Cardiac Monitor Market Size to Surpass US$ 773.78 billion by 2030 - Growth Plus Reports

Subjects
Cardiology -- Statistics -- Forecasts and trends, Prosthesis -- Statistics, Implants, Artificial -- Statistics, Atrial fibrillation -- Forecasts and trends -- Statistics, Patient monitoring equipment -- Statistics, Cardiovascular diseases -- Statistics -- Forecasts and trends, Heart -- Growth, Company growth, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

Newark, New Castle, USA, March 02, 2023 (GLOBE NEWSWIRE) -- According to the deep-dive market assessment study by Growth Plus Reports, the global https://www.globenewswire.com/Tracker?data=XuuvZtU_ppWXW7es5y5m6evzTytozepgXUo10vk6g1EhyNFZtHS7b-w3kq3pAy2L-hiAVhZKfBlzW6MgXPwK4WzjjlosQHTfJj8xLNPJ_flqsW__s8cDMkJTojZ2A58uTsjZTexf0Cm32YSLhwrL_ddWXhxvBKkD0ntoXd2ycIr1Ow5FeMnhNOADgqRShueW was valued at US$ 509.60 billion [...]

Published
2023

17. Investigators at University of Cincinnati Report Findings in Heart Disease (Pattern of Head Circumference Growth Following Bidirectional Glenn In Infants With Single Ventricle Heart Disease)

Subjects
Heart diseases -- Research, Congenital heart disease -- Research, Genetic disorders -- Research, Medical research -- Reports -- Health aspects, Medicine, Experimental -- Reports -- Health aspects, Infants -- Health aspects -- Research -- Reports, Epidemiology -- Research -- Reports -- Health aspects, Heart -- Growth, Physical fitness -- Health aspects -- Research -- Reports, Company growth, Health
Abstract

2021 AUG 21 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on Heart Disorders and Diseases - Heart Disease is [...]

Published
2021

18. Outlook on the Atrial Fibrillation Treatment Global Market to 2027 - Rising Prevalence of Cardiovascular Diseases Drives Growth

Subjects
Heart beat -- Growth, Atrial fibrillation -- Statistics, Cardiovascular diseases -- Statistics, Heart -- Growth, Company growth, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following news release: The 'Atrial Fibrillation Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027' report has been added to [...]

Published
2022

19. Recent Findings from Nanjing University Has Provided New Information about Heart Failure (Study On the Value of Serum Growth Differentiation Factor-15 Combined With B-type Urinary Natriuretic Peptide Precursor In the Diagnosis and Prognosis of ...)

Subjects
Medical research, Medicine, Experimental, Natriuretic peptides -- Growth, Heart -- Growth, Physical fitness -- Research, Heart failure -- Diagnosis -- Research -- Prognosis, Company growth, Health, Nanjing University -- Growth
Abstract

2021 FEB 6 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in Heart Disorders and Diseases - Heart Failure. [...]

Published
2021

20. New Ventricular Fibrillation Study Findings Recently Were Reported by Researchers at Germans Trias i Pujol Hospital (Growth Differentiation Factor-15 Is a Predictive Biomarker In Primary Ventricular Fibrillation: the Ruti-stemi-pvf Study)

Subjects
Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Muscle contraction -- Abnormalities, Cardiac patients -- Prognosis, Heart -- Growth, Physical fitness -- Health aspects -- Research, Company growth, Health
Abstract

2021 FEB 6 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Heart Disorders and Diseases - Ventricular Fibrillation. [...]

Published
2021

21. Researchers from Stanford University Describe Findings in Gene Therapy (Signalosome-regulated Serum Response Factor Phosphorylation Determining Myocyte Growth In Width Versus Length As a Therapeutic Target for Heart Failure)

Subjects
Genetic research -- Health aspects -- Growth, Gene therapy -- Health aspects, Heart -- Growth, Physical fitness -- Health aspects, Heart failure -- Health aspects, Company growth, Health, Stanford University -- Growth
Abstract

2021 JAN 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Biotechnology - Gene Therapy have been published. According [...]

Published
2021

22. Ventricular Assist Devices Market Size Share Trends Growth Demand and Competitive Analysis Insights 2022-2029 | DataM Intelligence

Subjects
Cardiac patients -- Forecasts and trends, Heart -- Growth, Company growth, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-November 7, 2022-: Ventricular Assist Devices Market Size Share Trends Growth Demand and Competitive Analysis Insights 2022-2029 | DataM Intelligence (C)1994-2022 M2 COMMUNICATIONS RDATE:04112022 Ventricular Assist Devices Market is [...]

Published
2022

23. Cardiac Arrest Treatment Market Size Share Trends Growth Demand and Competitive Analysis Insights 2022-2029 | DataM Intelligence

Subjects
Heart -- Growth, Cardiac arrest -- Statistics -- Forecasts and trends, Company growth, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-November 7, 2022-: Cardiac Arrest Treatment Market Size Share Trends Growth Demand and Competitive Analysis Insights 2022-2029 | DataM Intelligence (C)1994-2022 M2 COMMUNICATIONS RDATE:04112022 Cardiac Arrest Treatment Market is [...]

Published
2022

24. RetinalGeniX Technologies, Inc. to Present at the Emerging Growth Conference Wednesday, October 26, 2022

Subjects
Heart diseases, Heart -- Growth, Medical screening, Company growth, Banking, finance and accounting industries, Business
Abstract

PETALUMA, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) -- RetinalGeniX Technologies, Inc. OTCQB: RTGN to Present at the Emerging Growth Conference. https://www.globenewswire.com/Tracker?data=jg89Mxl6OtHvAx0YzJzYMUo11I0m_hCmdqAbXZcJ6Ktpcz3jE5af2H8ptmVMn0TCNHm8OtQlWx5Lkp5WOLq54Da4YWNjdCPO1lDUl7KsJq0= (RTGN) is pleased to announce that it has been [...]

Published
2022

25. Findings from Peking University Provides New Data on Atrial Fibrillation (The Predictive Value of Growth Differentiation Factor-15 In Recurrence of Atrial Fibrillation After Catheter Ablation)

Subjects
Physical fitness -- Research -- Reports, Atrial fibrillation -- Research, Ablation (Surgery) -- Reports -- Research, Medical research -- Reports, Heart -- Growth, Company growth, Health, Beijing University -- Reports -- Growth
Abstract

2020 OCT 17 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on Heart Disorders and Diseases - Atrial Fibrillation is [...]

Published
2020

26. Investigators at University of Heidelberg Release New Data on Heart Failure (Saraf-dependent activation of mTORC1 regulates cardiac growth)

Subjects
Heart failure, Angiotensin II, Women's health, Heart -- Growth, Death, Anopheles, Finance, Hypertrophy, Homeostasis, Diseases, Heart hypertrophy, Editors, Novels, Company growth, Health, Women's issues/gender studies
Abstract

2020 APR 2 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Fresh data on Heart Disorders and Diseases - Heart Failure are presented in a [...]

Published
2020

27. MacKay Memorial Hospital Researchers Advance Knowledge in Congenital Heart Defects (Prenatal diagnosis of concomitant distal 5q duplication and terminal 10q deletion in a fetus with intrauterine growth restriction, congenital diaphragmatic ...)

Subjects
Congenital heart defects, Physical fitness, Hernia, Heart -- Growth, Genetic disorders, Pregnant women, Anopheles, Finance, Coronary heart disease, Amniocentesis, Diaphragmatic hernia, Obesity, Editors, Company growth, Health
Abstract

2020 FEB 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in congenital heart defects. According to news reporting [...]

Published
2020

28. Acute Heart Failure Market to Register Stunning Growth During the Forecast Period (2019-32) | Key Companies - Boehringer Ingelheim, Eli Lilly, Windtree Therapeutics, Arena Pharma, and Others

Subjects
Boehringer Ingelheim GmbH -- Forecasts and trends, Eli Lilly and Co. -- Forecasts and trends, Business -- Research, Brand equity -- Forecasts and trends, Heart -- Growth, Heart failure -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Company growth, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-August 25, 2022-: Acute Heart Failure Market to Register Stunning Growth During the Forecast Period (2019-32) | Key Companies - Boehringer Ingelheim, Eli Lilly, Windtree Therapeutics, Arena Pharma, and [...]

Published
2022

29. Mobile Cardiac Telemetry Systems Market to Record a CAGR of 9.01% - Rising Prevalence of Cardiac Diseases to Drive Growth - Technavio

Subjects
Cardiology -- Reports -- Forecasts and trends, Heart beat -- Growth, Cardiovascular diseases -- Reports -- Forecasts and trends, Cardiac patients -- Forecasts and trends -- Reports, Heart -- Growth, Company growth, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NEW YORK: Technavio has issued the following news release: Mobile cardiac telemetry systems are remote patient monitoring devices that record the electrical activity of the heart, which helps in the [...]

Published
2022

30. Acutus Medical Completes First Closing of Transaction with Medtronic and Debt Refinancing to Fund Strategic Growth Priorities

Subjects
Medtronic PLC -- Finance, Medical test kit industry -- Finance -- Growth, Medical equipment and supplies industry -- Finance -- Growth, Heart -- Growth, Company growth, Company financing, Banking, finance and accounting industries, Business
Abstract

CARLSBAD, Jul 01, 2022 (GLOBE NEWSWIRE via COMTEX) -- EQNX::TICKER_START (NASDAQ:AFIB), EQNX::TICKER_END Acutus Medical, Inc. ('Acutus' or the 'Company') (Nasdaq: AFIB), an arrhythmia management company focused on improving the way [...]

Published
2022

31. Findings from First Affiliated Hospital of Nanjing Medical University in the Area of Heart Failure Described (Growth differentiation factor-15 combined with N-terminal prohormone of brain natriuretic peptide increase 1-year prognosis prediction ...)

Subjects
Heart failure -- Prognosis -- Research, Brain -- Growth, Physical fitness, Medical research, Cardiac patients -- Prognosis, Heart -- Growth, Natriuretic peptides -- Growth, Hospital patients, Obesity, Peptides, Biological markers, Editors, Company growth, Health
Abstract

2019 DEC 7 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Heart Disorders and Diseases - Heart Failure have [...]

Published
2019

32. Atrial Fibrillation Surgery Market to Record a 13.54% Y-O-Y Growth Rate in 2022 | Evolving Opportunities with Abbott Laboratories & AtriCure Inc |17000+ Technavio Reports

Subjects
AtriCure Inc. -- Forecasts and trends, Philips Gloeilampenfabrieken N.V. -- Forecasts and trends, Siemens Healthineers AG -- Forecasts and trends, Medtronic PLC -- Forecasts and trends, Johnson & Johnson -- Forecasts and trends, General Electric Co. -- Forecasts and trends, Abbott Laboratories (Abbott Park, Illinois) -- Forecasts and trends, Boston Scientific Corp. -- Forecasts and trends, Medical test kit industry -- Forecasts and trends, Atrial fibrillation -- Forecasts and trends, Ablation (Surgery) -- Forecasts and trends, Medical equipment and supplies industry -- Forecasts and trends, Electronics industry -- Forecasts and trends, Heart -- Growth, Electrical equipment and supplies industry -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Surgery -- Forecasts and trends, Company growth, Market trend/market analysis, Electronics industry, Business, News, opinion and commentary
Abstract

NEW YORK, March 25, 2022 /PRNewswire/ -- The https://www.technavio.com/report/atrial-fibrillation-surgery-market-industry-analysis?utm_source=prnewswire&utm_medium=pressrelease&utm_campaign=t47_e_report_wk13_2022_003&utm_content=IRTNTR72868 The atrial fibrillation surgery market value is anticipated to grow byUSD 1.89 billion , progressing at aCAGR of 14.17%. Also, the [...]

Published
2022

33. Dilated Cardiomyopathy Therapeutics Market Growth, Industry Outlook and Opportunities 2022 - 2029 | DataM Intelligence

Subjects
Cardiomyopathy, Dilated, Heart -- Growth, Company growth, Business, Business, international
Abstract

M2 PRESSWIRE-March 4, 2022-: Dilated Cardiomyopathy Therapeutics Market Growth, Industry Outlook and Opportunities 2022 - 2029 | DataM Intelligence (C)1994-2022 M2 COMMUNICATIONS RDATE:03032022 The Global Dilated Cardiomyopathy Therapeutics Market is [...]

Published
2022

34. Global Cardiac Arrhythmia Monitoring Devices Market Outlook, 2027: Current Data and Growth Projections for ECG Monitors, Implantable Monitors, Holter Monitors, Mobile Cardiac Telematory, and Others

Subjects
Prosthesis -- Reports, Implants, Artificial -- Reports, Arrhythmia -- Reports, Electrocardiography -- Reports, Patient monitoring equipment -- Reports, Electrocardiogram -- Reports, Heart -- Growth, Company growth, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Global Cardiac Arrhythmia Monitoring Devices Market, Size, Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Company Analysis' report has [...]

Published
2022

35. Global Cardiac Arrhythmia Monitoring Devices Market Outlook, 2027: Current Data and Growth Projections for ECG Monitors, Implantable Monitors, Holter Monitors, Mobile Cardiac Telematory, and Others - ResearchAndMarkets.com

Subjects
Prosthesis -- Reports, Implants, Artificial -- Reports, Arrhythmia -- Reports, Electrocardiography -- Reports, Patient monitoring equipment -- Reports, Electrocardiogram -- Reports, Heart -- Growth, Company growth, Business, Business, international
Abstract

DUBLIN -- The 'Global Cardiac Arrhythmia Monitoring Devices Market, Size, Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Company Analysis' report has been added to ResearchAndMarkets.com's offering. The Global Cardiac [...]

Published
2022

36. Global Cardiac Arrhythmia Monitoring Devices Market Outlook, 2027: Current Data and Growth Projections for ECG Monitors, Implantable Monitors, Holter Monitors, Mobile Cardiac Telematory, and Others

Subjects
Prosthesis -- Reports, Implants, Artificial -- Reports, Arrhythmia -- Reports, Electrocardiography -- Reports, Patient monitoring equipment -- Reports, Electrocardiogram -- Reports, Heart -- Growth, Company growth, Business, Business, international
Abstract

M2 PRESSWIRE-February 25, 2022-: Global Cardiac Arrhythmia Monitoring Devices Market Outlook, 2027: Current Data and Growth Projections for ECG Monitors, Implantable Monitors, Holter Monitors, Mobile Cardiac Telematory, and Others (C)1994-2022 [...]

Published
2022

37. Congestive Heart Failure (CHF) Treatment Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

Subjects
United States. Food and Drug Administration -- Reports, Mortality -- North America, Congestive heart failure -- Forecasts and trends -- Health aspects -- Reports, Arrhythmia -- Reports -- Health aspects -- Forecasts and trends, Heart -- Growth, Cardiac patients -- Health aspects -- Forecasts and trends -- Reports, Company growth, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

New York, Dec 15, 2021 (GLOBE NEWSWIRE via COMTEX) -- Reportlinker.com announces the release of the report 'Congestive Heart Failure (CHF) Treatment Devices Market - Growth, Trends, COVID-19 Impact, and [...]

Published
2021

38. Global Electrophysiology Devices Market Opportunities Report 2021: Robotic Navigation Systems for EP Procedures will Accelerate the Growth of the Market

Subjects
Electronics in navigation -- Reports, Arrhythmia -- Reports, Heart -- Growth, Company growth, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Growth Opportunities in Global Electrophysiology Devices' report has been added to ResearchAndMarkets.com's offering. The electrophysiology (EP) service line has [...]

Published
2021

39. Global Electrophysiology Devices Market Growth Opportunities 2021: The Emergence of Technologies such as Neuromodulation will Create a New Market for Arrhythmia Therapies

Subjects
Cardiovascular agents, Arrhythmia, Heart -- Growth, Company growth, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Growth Opportunities in Global Electrophysiology Devices' report has been added to ResearchAndMarkets.com's offering. The electrophysiology (EP) service line has [...]

Published
2021

40. Global Electrophysiology Devices Market Opportunities Report 2021: Robotic Navigation Systems for EP Procedures will Accelerate the Growth of the Market

Subjects
Electronics in navigation -- Reports, Arrhythmia -- Reports, Heart -- Growth, Company growth, Business, News, opinion and commentary
Abstract

DUBLIN, Dec. 14, 2021 /PRNewswire/ -- The 'Growth Opportunities in Global Electrophysiology Devices' report has been added toResearchAndMarkets.com's offering. The electrophysiology (EP) service line has grown leaps and bounds in [...]

Published
2021

41. Global Electrophysiology Devices Market Growth Opportunities 2021: The Emergence of Technologies such as Neuromodulation will Create a New Market for Arrhythmia Therapies - ResearchAndMarkets.com

Subjects
Cardiovascular agents, Arrhythmia, Heart -- Growth, Company growth, Business, Business, international
Abstract

DUBLIN -- The 'Growth Opportunities in Global Electrophysiology Devices' report has been added to ResearchAndMarkets.com's offering. The electrophysiology (EP) service line has grown leaps and bounds in the past decade, [...]

Published
2021

42. United States Cardiovascular Devices Market 2021-2027: Increasing Burden of CV Diseases and Increased Adoption of Minimally Invasive Procedures Driving Growth

Subjects
Abbott Laboratories (Abbott Park, Illinois) -- Forecasts and trends, Heart diseases -- Health aspects -- Forecasts and trends, Cardiovascular equipment -- Forecasts and trends -- Health aspects, Heart -- Growth, Pharmaceutical industry -- Forecasts and trends, Company growth, Market trend/market analysis, Business, News, opinion and commentary
Abstract

DUBLIN, Dec. 6, 2021 /PRNewswire/ -- The 'United States Cardiovascular Devices Market Forecast 2021-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis' report has been added toResearchAndMarkets.com's offering. United [...]

Published
2021

43. United States Cardiovascular Devices Market Forecasts 2021-2027: Industry Trends, Growth, Impact of COVID-19, Opportunities, Company Analysis - ResearchAndMarkets.com

Subjects
Abbott Laboratories (Abbott Park, Illinois) -- Forecasts and trends, Heart diseases -- Health aspects -- Reports -- Forecasts and trends, Cardiovascular equipment -- Reports -- Forecasts and trends -- Health aspects, Heart -- Growth, Pharmaceutical industry -- Forecasts and trends, Company growth, Market trend/market analysis, Business, Business, international
Abstract

DUBLIN -- The 'United States Cardiovascular Devices Market Forecast 2021-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis' report has been added to ResearchAndMarkets.com's offering. United States Cardiovascular Devices [...]

Published
2021

44. New Findings from University of Pennsylvania in Heart Failure Provides New Insights (Relationship Between Serum Brain-type Natriuretic Peptide and Biomarkers of Growth In Infants With Shunt-dependent Single Cardiac Ventricle)

Subjects
Brain -- Growth, Medical research -- Reports, Medicine, Experimental -- Reports, Infants -- Reports -- Research, Natriuretic peptides -- Growth, Heart -- Growth, Heart failure -- Research, Company growth, Health, University of Pennsylvania -- Reports -- Growth
Abstract

2022 AUG 26 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Fresh data on Heart Disorders and Diseases - Heart Failure are presented in [...]

Published
2022

45. Coordination of heart and lung co-development by a multipotent cardiopulmonary progenitor

Author

Peng, Tien, Tian, Ying, Boogerd, Cornelis J., Lu, Min Min, Kadzik, Rachel S., Stewart, Kathleen M., Evans, Sylvia M., and Morrisey, Edward E.

Subjects
Embryonic development -- Research, Heart -- Growth, Lungs -- Growth, Company growth, Environmental issues, Science and technology, Zoology and wildlife conservation
Abstract

Co-development of the cardiovascular and pulmonary systems is a recent evolutionary adaption to terrestrial life that couples cardiac output with the gas exchange function of the lung (1). Here we [...]

Published
2013

46. Cardiac Arrhythmia Monitoring Devices Market 2021 Is Booming Growth Across the Globe and Forecast to 2031 | insightSLICE

Subjects
Marketing research -- Reports, Patient monitoring equipment -- Market research, Heart -- Growth, Company growth, Marketing research, Business, Business, international
Abstract

M2 PRESSWIRE-November 12, 2021-: Cardiac Arrhythmia Monitoring Devices Market 2021 Is Booming Growth Across the Globe and Forecast to 2031 | insightSLICE (C)1994-2021 M2 COMMUNICATIONS RDATE:11112021 According to insightSLICE, the [...]

Published
2021

47. skNAC, a Smyd1-interacting transcription factor, is involved in cardiac development and skeletal muscle growth and regeneration

Author

Park, Chong Yon, Pierce, Stephanie A., von Drehle, Morgan, Ivey, Kathryn N., Morgan, Jayson A., Blau, Helen M., and Srivastava, Deepak

Subjects
Proteins -- Growth, Proteins -- Research, Transcription factors -- Research, Heart -- Growth, Muscles -- Growth, Muscles -- Regeneration, Muscles -- Research, Company growth, Science and technology
Abstract

Cardiac and skeletal muscle development and maintenance require complex interactions between DNA-binding proteins and chromatin remodeling factors. We previously reported that Smyd1, a muscle-restricted histone methyltransferase, is essential for cardiogenesis and functions with a network of cardiac regulatory proteins. Here we show that the muscle-specific transcription factor skNAC is the major binding partner for Smyd1 in the developing heart. Targeted deletion of skNAC in mice resulted in partial embryonic lethality by embryonic day 12.5, with ventricular hypoplasia and decreased cardiomyocyte proliferation that were similar but less severe than in Smyd1 mutants. Expression of Irx4, a ventricle-specific transcription factor down-regulated in hearts lacking Smyd1, also depended on the presence of skNAC. Viable [skNAC.sup.-/-] adult mice had reduced postnatal skeletal muscle growth and impaired regenerative capacity after cardiotoxin-induced injury. Satellite cells isolated from [skNAC.sup.-/-] mice had impaired survival compared with wild-type littermate satellite cells. Our results indicate that skNAC plays a critical role in ventricular cardiomyocyte expansion and regulates postnatal skeletal muscle growth and regeneration in mice. doi/ 10.1073/pnas.1013493107

Published
2010

48. Cardiac conduction is required to preserve cardiac chamber morphology

Author

Chi, Neil C., Bussen, Markus, Brand-Arzamendi, Koroboshka, Ding, Chunhua, Olgin, Jeffrey E., Shaw, Robin M., Martin, Gail R., and Stainier, Didier Y.R.

Subjects
Gene expression -- Research, Morphogenesis -- Research, Heart -- Growth, Heart -- Genetic aspects, Company growth, Science and technology
Abstract

Electrical cardiac forces have been previously hypothesized to play a significant role in cardiac morphogenesis and remodeling. In response to electrical forces, cultured cardiomyocytes rearrange their cytoskeletal structure and modify their gene expression profile. To translate such in vitro data to the intact heart, we used a collection of zebrafish cardiac mutants and transgenics to investigate whether cardiac conduction could influence in vivo cardiac morphogenesis independent of contractile forces. We show that the cardiac mutant [dco.sup.s226] develops heart failure and interrupted cardiac morphogenesis following uncoordinated ventricular contraction. Using in vivo optical mapping/calcium imaging, we determined that the dco cardiac phenotype was primarily due to aberrant ventricular conduction. Because cardiac contraction and intracardiac hemodynamic forces can also influence cardiac development, we further analyzed the dco phenotype in noncontractile hearts and observed that disorganized ventricular conduction could affect cardiomyocyte morphology and subsequent heart morphogenesis in the absence of contraction or flow. By positional cloning, we found that dco encodes Gja3/Cx46, a gap junction protein not previously implicated in heart formation or function. Detailed analysis of the mouse Cx46 mutant revealed the presence of cardiac conduction defects frequently associated with human heart failure. Overall, these in vivo studies indicate that cardiac electrical forces are required to preserve cardiac chamber morphology and may act as a key epigenetic factor in cardiac remodeling. connexin | development | electrophysiology | genetics | heart doi/ 10.1073/pnas.0909432107

Published
2010

49. c-Abl tyrosine kinase regulates cardiac growth and development

Author

Qiu, Zhaozhu, Cang, Yong, and Goff, Stephen P.

Subjects
Tyrosine -- Physiological aspects, Phosphotransferases -- Physiological aspects, Heart -- Growth, Company growth, Science and technology
Abstract

The c-Abl protein is a ubiquitously expressed nonreceptor tyrosine kinase involved in the development and function of many mammalian organ systems, including the immune system and bone. Here we show that homozygous Abl mutant embryos and newborns on the C57BL/6J background, but not on other backgrounds, display dramatically enlarged hearts and die perinatally. The heart defects can be largely rescued by cardiomyocyte-specific restoration of the full-length c-Abl protein. The cardiac hyperplasia phenotype is not caused by decreased apoptosis, but rather by abnormally increased cardiomyocyte proliferation during later stages of embryogenesis. Genes involved in cardiac stress and remodeling and cell cycle regulation are also up-regulated in the mutant hearts. These findings reveal an essential role for c-Abl in mammalian heart growth and development. Abelson | heart development | hyperproliferation doi/10.1073/pnas.0913131107

Published
2010

50. Protein tyrosine phosphatase activity in the neural crest is essential for normal heart and skull development

Author

Nakamura, Tomoki, Gulick, James, Colbert, Melissa C., and Robbins, Jeffrey

Subjects
Tyrosine -- Physiological aspects, Phosphatases -- Physiological aspects, Embryonic development -- Research, Neural crest -- Growth, Heart -- Growth, Company growth, Science and technology
Abstract

Mutations within the protein tyrosine phosphatase, SHP2, which is encoded by PTPN11, cause a significant proportion of Noonan syndrome (NS) cases, typically presenting with both cardiac disease and craniofacial abnormalities. Neural crest cells (NCCs) participate in both heart and skull formation, but the role of SHP2 signaling in NCC has not yet been determined. To gain insight into the role of SHP2 in NCC function, we ablated PTPN11 specifically in premigratory NCCs. SHP2-deficient NCCs initially exhibited normal migratory and proliferative patterns, but in the developing heart failed to migrate into the developing outflow tract. The embryos displayed persistent truncus arteriosus and abnormalities of the great vessels. The craniofacial deficits were even more pronounced, with large portions of the face and cranium affected, including the mandible and frontal and nasal bones. The data show that SHP2 activity in the NCC is essential for normal migration and differentiation into the diverse lineages found in the heart and skull and demonstrate the importance of NCC-based normal SHP2 activity in both heart and skull development, providing insight into the syndromic presentation characteristic of NS.

Published
2009

Catalog

Books, media, physical & digital resources
See catalog results